摘要
维生素D长时间以来一直是钙磷平衡以及随着甲状旁腺激素(PTH)动态平衡的主要因素。维生素D对钙和磷的影响是完全已知的,但最近的研究试图将维生素D的状态和心血管疾病联系起来。 维生素D重塑血管是由如肾素-血管紧张素-醛固酮系统(RAAS)的激活,细胞增殖和抗凋亡的细胞通路等多种机制所介导的。这种相关性可以被以下事实所突出,维生素D的活性形式(1,25(OH)2 D3)由于存在内皮1α-羟化酶的结构,因此可以通过相同的内皮细胞合成。维生素D降低了内皮细胞表面(AT2R)的血管紧张素2号受体(AT2R)的表达,产生了一系列事件,导致了如一氧化氮等血管扩张剂的合成。内皮细胞上的维生素D受体(VDR)的激活诱导了血管内皮细胞的代谢活动的变化,同时负责细胞存活、增殖和新生血管形成。此外,由于基因多态性的改变而引起的VDR信号已被证明可以治疗心脏疾病、慢性肾脏疾病(CKD)等。最近,血管通路的结果已经与维生素D状态联系起来了。未来的研究将有助于更好地定义心血管补充维生素D的必要性以及其与CKD患者血管通路的结果。
关键词: 动脉粥样硬化;内皮细胞;平滑肌细胞;血管通路;维生素D。
Current Medicinal Chemistry
Title:Role of Vitamin D in Vascular Complications and Vascular Access Outcome in Patients with Chronic Kidney Disease
Volume: 23 Issue: 17
Author(s): Domenico Santoro, Vincenzo Pellicanò, Valeria Cernaro, Viviana Lacava, Antonio Lacquaniti, Marco Atteritano, Michele Buemi
Affiliation:
关键词: 动脉粥样硬化;内皮细胞;平滑肌细胞;血管通路;维生素D。
摘要: Vitamin D has been known for a long time as a major factor involved in the calcium- phosphate balance and homeostasis, along with parathyroid hormone (PTH). While vitamin D effects on calcium and phosphate are fully known, recent studies attempted to link vitamin D status and cardiovascular diseases.
The involvement of vitamin D on vascular remodeling is mediated by several mechanisms such as activation of renin-angiotensin-aldosterone system (RAAS), cell proliferation and anti-apoptotic cell pathways. This correlation is highlighted by the fact that the activated form of vitamin D (1,25 (OH)2 D3) can be synthesized by the same endothelial cells, due to the constitutive presence of endothelial 1α-hydroxylase. Vitamin D reduces the expression of angiotensin 2 receptor (AT2R) on the endothelial cell surface (AT2R), leading to a cascade of events that result in the synthesis of vasodilators, such as nitric oxide. The activation of vitamin D receptors (VDRs) on endothelial cells induces changes in the metabolic activity of the endothelium and is responsible for cell survival, proliferation and neoangiogenesis. Moreover, altered signaling of VDR due to gene polymorphisms has been demonstrated in patients with cardiac disorders and chronic kidney disease (CKD). Recently, vascular access outcome has been associated with vitamin D status. Future studies will help to better define the need of vitamin D supplementation for a better cardiovascular as well as vascular access outcome in patients with CKD.
Export Options
About this article
Cite this article as:
Domenico Santoro, Vincenzo Pellicanò, Valeria Cernaro, Viviana Lacava, Antonio Lacquaniti, Marco Atteritano, Michele Buemi , Role of Vitamin D in Vascular Complications and Vascular Access Outcome in Patients with Chronic Kidney Disease, Current Medicinal Chemistry 2016; 23 (17) . https://dx.doi.org/10.2174/0929867323666160405112019
DOI https://dx.doi.org/10.2174/0929867323666160405112019 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Pharmacogenetic Applications of the Post Genomic Era
Current Pharmaceutical Biotechnology Abelson Tyrosine-Protein Kinase 1 as Principal Target for Drug Discovery Against Leukemias. Role of the Current Computer-Aided Drug Design Methodologies
Current Topics in Medicinal Chemistry Role of Angiopoietin-like 4 (ANGPTL4), a Member of Matricellular Proteins: from Homeostasis to Inflammation and Cancer Metastasis
Current Angiogenesis (Discontinued) Gene Delivery for Cancer Therapy
Current Drug Delivery TRPV1: On the Road to Pain Relief
Current Molecular Pharmacology The Role of Amitriptyline in the Management of Non-small Cell Lung Cancer
Current Cancer Therapy Reviews Applications of Recombinant Adenovirus-p53 Gene Therapy for Cancers in the Clinic in China
Current Gene Therapy Src Inhibitors as Potential Therapeutic Agents for Human Cancers
Mini-Reviews in Medicinal Chemistry HIV-1 Protease Inhibitors: A Comparative QSAR Analysis
Current Medicinal Chemistry Biomarkers and Future Targets for Development in Amyotrophic Lateral Sclerosis
Current Medicinal Chemistry Design of New Drug Molecules to be Used in Reversing Multidrug Resistance in Cancer Cells
Current Cancer Drug Targets Recent Development in Nano-Sized Dosage Forms of Plant Alkaloid Camptothecin-Derived Drugs
Recent Patents on Anti-Cancer Drug Discovery Heparin, Heparan Sulfate and Heparanase in Cancer: Remedy for Metastasis?
Anti-Cancer Agents in Medicinal Chemistry Action of Nanoparticles on Platelet Activation and Plasmatic Coagulation
Current Medicinal Chemistry Large-Scale Production Means for the Manufacturing of Lentiviral Vectors
Current Gene Therapy The Safety and Efficacy of Parathyroid Hormone (PTH) as a Biological Response Modifier for the Enhancement of Bone Regeneration
Current Drug Safety Applications of Lentiviral Vectors for Biology and Gene Therapy of Neurological Disorders
Current Gene Therapy Novel Therapeutic Approaches to Regulate Human Dihydrofolate Reductase Activity and Expression
Current Enzyme Inhibition Isoenzyme Selective Phosphoinositide 3-Kinase Inhibition: What do the Stones Kill?
Current Signal Transduction Therapy Editorial (Thematic Issue: Research and Regulation: Challenges of Nanoproducts)
Recent Patents on Nanomedicine